CENTELLIAN24+ Madeca Cream Time Reverse 1.69oz / 50ml Anti-aging K-Beauty

$ 4.54

Department: Unisex Unit Type: fl oz Sun Protection Factor (SPF): SPF Features: Sensitive skin irritation test completed, Completed skin hypoallergenic test, Original Derma test Excellent, Dermatologically Tested, Hypoallergenic Volume: 1.69 fl.oz UVA Protection: See description for details Period After Opening (PAO): 12M Formulation: Cream Type: Moisturizer Product Line: CENTELLIAN24+ Madeca Cream Time Reverse Ingredients: Adenosine, Panthenol, Niacinamide, Asiatic Acid, AQUAXYL, Ectoin, Glycogen Set Includes: Day & Night Treatment Body Area: Face Skin Type: All Skin Types Main Purpose: Acne, Age Spots, Blemishes, Wrinkles Brand: Centellian 24 Active Ingredients: Centella asiatica leaf extract, Centella Asiatica Protein Extract, Madecassic Acid, Centella asiatica amino acid, Madecassoside, Asiaticoside, Hyaluronic Acid Size: Regular

Description

CENTELLIAN24+ Madeca Cream Time Reverse 1.69oz / 50ml Anti-aging K-Beauty. Capacity : 50ml / 1.69 fl.oz. -After washing your face in the morning and evening, take an appropriate amount and apply it gently all over your face to absorb it. Skin type : All Skin Types. CENTELLIAN24+ Madeca Cream Time Reverse 1.69oz / 50ml Anti-aging K-Beauty Features #Total-Slow-Aging #Hyper-Anti-Aging -We used only heavily concentrated TECA, which was only 2% obtained from 100 kg of centella asiatica. -Elasticity, moisturization, wrinkles, blemishes, freckles, blemishes, anti-aging effects, and collagen ingredients last 72 hours. -It contains high-content ingredients in the three-stage separation liposome and delivers them densely to the deep skin. -Immediately improves skin elasticity in 30 sagging facial areas. How To Use -After washing your face in the morning and evening, take an appropriate amount and apply it gently all over your face to absorb it. Item Specification * Condition : 100 % Brand New * Skin type : All Skin Types * Capacity : 50ml / 1.69 fl.oz On May 15, 2026 at 00:35:39 PDT, seller added the following information: